Nikolaj Sørensen, Board Member of Miiskin

Nikolaj Sørensen, MSc, is an experienced life science executive with deep expertise in pharmaceutical commercialization, digital health, and international corporate leadership. He is currently President & CEO of Orexo AB, bringing extensive knowledge of the U.S. insurance and reimbursement landscape and proven skills in pharmaceutical and digital product launches. His career includes senior management roles at Pfizer Inc., where he focused on European commercialization, and as Chairman and Managing Director at Pfizer AB. Earlier, as a Principal at Boston Consulting Group (BCG), he led M&A, commercial transformation, and turnaround projects across the life science sector. His strong investor connections across Sweden and the Nordic region further enhance his impact as a strategic advisor and board member.

Leadership roles:

• President & CEO and Board Member at Orexo AB
• Board Member at Moberg Pharma AB
• Board Member at Gesynta Pharma AB
• Board Member at Miiskin